BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30850927)

  • 21. Case Report: Interleukin-2 Receptor Common Gamma Chain Defect Presented as a Hyper-IgE Syndrome.
    Belaid B; Lamara Mahammed L; Mohand Oussaid A; Migaud M; Khadri Y; Casanova JL; Puel A; Ben Halla N; Djidjik R
    Front Immunol; 2021; 12():696350. PubMed ID: 34248995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice.
    Hiramoto T; Li LB; Funk SE; Hirata RK; Russell DW
    Mol Ther; 2018 May; 26(5):1255-1265. PubMed ID: 29606506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1.
    Mamcarz E; Zhou S; Lockey T; Abdelsamed H; Cross SJ; Kang G; Ma Z; Condori J; Dowdy J; Triplett B; Li C; Maron G; Aldave Becerra JC; Church JA; Dokmeci E; Love JT; da Matta Ain AC; van der Watt H; Tang X; Janssen W; Ryu BY; De Ravin SS; Weiss MJ; Youngblood B; Long-Boyle JR; Gottschalk S; Meagher MM; Malech HL; Puck JM; Cowan MJ; Sorrentino BP
    N Engl J Med; 2019 Apr; 380(16):1525-1534. PubMed ID: 30995372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Expanded Gamma Delta T Cells from Atypical X-SCID Patient Reveals Preserved Function and IL2RG-Mediated Signaling.
    Tuovinen EA; Pöysti S; Hamdan F; Le KM; Keskitalo S; Turunen T; Minier L; Mamia N; Heiskanen K; Varjosalo M; Cerullo V; Kere J; Seppänen MRJ; Hänninen A; Grönholm J
    J Clin Immunol; 2023 Feb; 43(2):358-370. PubMed ID: 36260239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo.
    Recher M; Berglund LJ; Avery DT; Cowan MJ; Gennery AR; Smart J; Peake J; Wong M; Pai SY; Baxi S; Walter JE; Palendira U; Tangye GA; Rice M; Brothers S; Al-Herz W; Oettgen H; Eibel H; Puck JM; Cattaneo F; Ziegler JB; Giliani S; Tangye SG; Notarangelo LD
    Blood; 2011 Dec; 118(26):6824-35. PubMed ID: 22039266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Il2rg gene-targeted severe combined immunodeficiency pigs.
    Suzuki S; Iwamoto M; Saito Y; Fuchimoto D; Sembon S; Suzuki M; Mikawa S; Hashimoto M; Aoki Y; Najima Y; Takagi S; Suzuki N; Suzuki E; Kubo M; Mimuro J; Kashiwakura Y; Madoiwa S; Sakata Y; Perry ACF; Ishikawa F; Onishi A
    Cell Stem Cell; 2012 Jun; 10(6):753-758. PubMed ID: 22704516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple reversions of an IL2RG mutation restore T cell function in an X-linked severe combined immunodeficiency patient.
    Kawai T; Saito M; Nishikomori R; Yasumi T; Izawa K; Murakami T; Okamoto S; Mori Y; Nakagawa N; Imai K; Nonoyama S; Wada T; Yachie A; Ohmori K; Nakahata T; Heike T
    J Clin Immunol; 2012 Aug; 32(4):690-7. PubMed ID: 22460439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal T and B cell engraftment in two cases of X-linked severe combined immunodeficiency with IgG1 gammopathy.
    Okano T; Nishikawa T; Watanabe E; Watanabe T; Takashima T; Yeh TW; Yamashita M; Tanaka-Kubota M; Miyamoto S; Mitsuiki N; Takagi M; Kawano Y; Mochizuki Y; Imai K; Kanegane H; Morio T
    Clin Immunol; 2017 Oct; 183():112-120. PubMed ID: 28780374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late-Onset Combined Immunodeficiency with a Novel IL2RG Mutation and Probable Revertant Somatic Mosaicism.
    Okuno Y; Hoshino A; Muramatsu H; Kawashima N; Wang X; Yoshida K; Wada T; Gunji M; Toma T; Kato T; Shiraishi Y; Iwata A; Hori T; Kitoh T; Chiba K; Tanaka H; Sanada M; Takahashi Y; Nonoyama S; Ito M; Miyano S; Ogawa S; Kojima S; Kanegane H
    J Clin Immunol; 2015 Oct; 35(7):610-4. PubMed ID: 26407811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector.
    Horino S; Uchiyama T; So T; Nagashima H; Sun SL; Sato M; Asao A; Haji Y; Sasahara Y; Candotti F; Tsuchiya S; Kure S; Sugamura K; Ishii N
    PLoS One; 2013; 8(8):e71594. PubMed ID: 23990961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy.
    Pike-Overzet K; van der Burg M; Wagemaker G; van Dongen JJ; Staal FJ
    Mol Ther; 2007 Nov; 15(11):1910-6. PubMed ID: 17726455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation and characterization of an
    Li R; Ying B; Liu Y; Spencer JF; Miao J; Tollefson AE; Brien JD; Wang Y; Wold WSM; Wang Z; Toth K
    Dis Model Mech; 2020 Aug; 13(8):. PubMed ID: 32651192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel X-linked mutation in IL2RG associated with early-onset inflammatory bowel disease: a case report of twin brothers.
    Rayzan E; Sadeghalvad M; Shahkarami S; Zoghi S; Aryan Z; Mahdaviani SA; Boztug K; Rezaei N
    J Med Case Rep; 2023 Jul; 17(1):307. PubMed ID: 37461086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Mutations in the IL2RG Gene in 2 Asian Infants With X-linked Severe Combined Immunodeficiency.
    Hara Y; Kobayashi N; Maruyama Y; Motobayashi M; Shigemura T; Ohara O; Agematsu K; Koike K
    J Investig Allergol Clin Immunol; 2015; 25(4):313-5. PubMed ID: 26310054
    [No Abstract]   [Full Text] [Related]  

  • 35. A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.
    Kuijpers TW; van Leeuwen EM; Barendregt BH; Klarenbeek P; aan de Kerk DJ; Baars PA; Jansen MH; de Vries N; van Lier RA; van der Burg M
    Haematologica; 2013 Jul; 98(7):1030-8. PubMed ID: 23403317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A New IL-2RG Gene Mutation in an X-linked SCID Identified through TREC/KREC Screening: a Case Report.
    Nourizadeh M; Borte S; Fazlollahi MR; Hammarström L; Pourpak Z
    Iran J Allergy Asthma Immunol; 2015 Aug; 14(4):457-61. PubMed ID: 26547715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe combined immunodeficiency in Greek children over a 20-year period: rarity of γc-chain deficiency (X-linked) type.
    Michos A; Tzanoudaki M; Villa A; Giliani S; Chrousos G; Kanariou M
    J Clin Immunol; 2011 Oct; 31(5):778-83. PubMed ID: 21732012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mutation in the IL-2 receptor gamma chain gene associated with X-linked severe combined immunodeficiency accompanying opisthotonus.
    Kashiwagi Y; Kawashima H; Kato N; Takekuma K; Hoshika A; Kumaki S
    Tohoku J Exp Med; 2009 May; 218(1):1-3. PubMed ID: 19398866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and mutation analysis of X-linked severe combined immunodeficiency in China.
    Zhang C; Zhang ZY; Wu JF; Tang XM; Yang XQ; Jiang LP; Zhao XD
    World J Pediatr; 2013 Feb; 9(1):42-7. PubMed ID: 22105576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limiting {gamma}c expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors.
    Smyth CM; Ginn SL; Deakin CT; Logan GJ; Alexander IE
    Blood; 2007 Jul; 110(1):91-8. PubMed ID: 17363735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.